Cargando…

VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation

OBJECTIVES: In glaucomatous eyes, the main aqueous humor (AH) outflow pathway is damaged by accumulated oxidative stress arising from the microenvironment, vascular dysregulation, and aging, which results in increased outflow resistance and ocular hypertension. Schlemm's canal (SC) serves as th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Xiaotong, Mou, Qianxue, Zhao, Bowen, Huang, Jingqiu, Yao, Ke, Luo, Zhaoxia, Ye, Meng, Hu, Yuanyuan, Duan, Qiming, Li, Xing, Wen, Zheng, Chen, Zhiqi, Zhang, Hong, Zhao, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452417/
https://www.ncbi.nlm.nih.gov/pubmed/34552687
http://dx.doi.org/10.1155/2021/9397960
_version_ 1784570061379338240
author Lou, Xiaotong
Mou, Qianxue
Zhao, Bowen
Huang, Jingqiu
Yao, Ke
Luo, Zhaoxia
Ye, Meng
Hu, Yuanyuan
Duan, Qiming
Li, Xing
Wen, Zheng
Chen, Zhiqi
Zhang, Hong
Zhao, Yin
author_facet Lou, Xiaotong
Mou, Qianxue
Zhao, Bowen
Huang, Jingqiu
Yao, Ke
Luo, Zhaoxia
Ye, Meng
Hu, Yuanyuan
Duan, Qiming
Li, Xing
Wen, Zheng
Chen, Zhiqi
Zhang, Hong
Zhao, Yin
author_sort Lou, Xiaotong
collection PubMed
description OBJECTIVES: In glaucomatous eyes, the main aqueous humor (AH) outflow pathway is damaged by accumulated oxidative stress arising from the microenvironment, vascular dysregulation, and aging, which results in increased outflow resistance and ocular hypertension. Schlemm's canal (SC) serves as the final filtration barrier of the main AH outflow pathway. The present study is aimed at investigating the possible regulation of vasoactive intestinal peptide (VIP) on the cytoskeleton by stabilizing ZO-1 in SC. METHODS: Model of chronic ocular hypertension (COH) induced by episcleral venous cauterization was treated with topical VIP. The ultrastructure of junctions, ZO-1 levels, and permeability of the SC inner wall to FITC-dextran (70 kDa) were detected in the COH models. The F-actin distribution, F/G-actin ratio, and ZO-1 degradation pathway in human umbilical vein endothelial cells (HUVECs) and HEK 293 cells were investigated. RESULTS: ZO-1 in the outer wall of the SC was less than that in the inner wall. COH elicited junction disruption, ZO-1 reduction, and increased permeability of the SC inner wall to FITC-dextran in rats. ZO-1 plays an essential role in maintaining the F/G-actin ratio and F-actin distribution. VIP treatment attenuated the downregulation of ZO-1 associated with COH or H(2)O(2)-induced oxidative damage. In H(2)O(2)-stimulated HUVECs, the caspase-3 inhibitor prevents ZO-1 disruption. Caspase-3 activation promoted endolysosomal degradation of ZO-1. Furthermore, a decrease in caspase-3 activation and cytoskeleton redistribution was demonstrated in VIP + H(2)O(2)-treated cells. The knockdown of ZO-1 or the overexpression of caspase-3 blocked the effect of VIP on the cytoskeleton. CONCLUSION: This study provides insights into the role of VIP in stabilizing the interaction between the actin cytoskeleton and cell junctions and may provide a promising targeted strategy for glaucoma treatment.
format Online
Article
Text
id pubmed-8452417
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-84524172021-09-21 VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation Lou, Xiaotong Mou, Qianxue Zhao, Bowen Huang, Jingqiu Yao, Ke Luo, Zhaoxia Ye, Meng Hu, Yuanyuan Duan, Qiming Li, Xing Wen, Zheng Chen, Zhiqi Zhang, Hong Zhao, Yin Oxid Med Cell Longev Research Article OBJECTIVES: In glaucomatous eyes, the main aqueous humor (AH) outflow pathway is damaged by accumulated oxidative stress arising from the microenvironment, vascular dysregulation, and aging, which results in increased outflow resistance and ocular hypertension. Schlemm's canal (SC) serves as the final filtration barrier of the main AH outflow pathway. The present study is aimed at investigating the possible regulation of vasoactive intestinal peptide (VIP) on the cytoskeleton by stabilizing ZO-1 in SC. METHODS: Model of chronic ocular hypertension (COH) induced by episcleral venous cauterization was treated with topical VIP. The ultrastructure of junctions, ZO-1 levels, and permeability of the SC inner wall to FITC-dextran (70 kDa) were detected in the COH models. The F-actin distribution, F/G-actin ratio, and ZO-1 degradation pathway in human umbilical vein endothelial cells (HUVECs) and HEK 293 cells were investigated. RESULTS: ZO-1 in the outer wall of the SC was less than that in the inner wall. COH elicited junction disruption, ZO-1 reduction, and increased permeability of the SC inner wall to FITC-dextran in rats. ZO-1 plays an essential role in maintaining the F/G-actin ratio and F-actin distribution. VIP treatment attenuated the downregulation of ZO-1 associated with COH or H(2)O(2)-induced oxidative damage. In H(2)O(2)-stimulated HUVECs, the caspase-3 inhibitor prevents ZO-1 disruption. Caspase-3 activation promoted endolysosomal degradation of ZO-1. Furthermore, a decrease in caspase-3 activation and cytoskeleton redistribution was demonstrated in VIP + H(2)O(2)-treated cells. The knockdown of ZO-1 or the overexpression of caspase-3 blocked the effect of VIP on the cytoskeleton. CONCLUSION: This study provides insights into the role of VIP in stabilizing the interaction between the actin cytoskeleton and cell junctions and may provide a promising targeted strategy for glaucoma treatment. Hindawi 2021-09-13 /pmc/articles/PMC8452417/ /pubmed/34552687 http://dx.doi.org/10.1155/2021/9397960 Text en Copyright © 2021 Xiaotong Lou et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lou, Xiaotong
Mou, Qianxue
Zhao, Bowen
Huang, Jingqiu
Yao, Ke
Luo, Zhaoxia
Ye, Meng
Hu, Yuanyuan
Duan, Qiming
Li, Xing
Wen, Zheng
Chen, Zhiqi
Zhang, Hong
Zhao, Yin
VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation
title VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation
title_full VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation
title_fullStr VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation
title_full_unstemmed VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation
title_short VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation
title_sort vip stabilizes the cytoskeleton of schlemm's canal endothelia via reducing caspase-3 mediated zo-1 endolysosomal degradation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452417/
https://www.ncbi.nlm.nih.gov/pubmed/34552687
http://dx.doi.org/10.1155/2021/9397960
work_keys_str_mv AT louxiaotong vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT mouqianxue vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT zhaobowen vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT huangjingqiu vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT yaoke vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT luozhaoxia vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT yemeng vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT huyuanyuan vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT duanqiming vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT lixing vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT wenzheng vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT chenzhiqi vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT zhanghong vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation
AT zhaoyin vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation